About Sobi
Sobi is a global biopharma company dedicated to developing and delivering innovative therapies for rare diseases. We have built a robust foundation in rare disease management, achieving a global reach through innovative practices. Our mission is to address areas of high unmet medical need and improve patient outcomes through science-driven solutions.
- Scientific focus: We identify and develop novel therapies based on cutting-edge science.
- Clinical impact: Our goal is to provide healthcare professionals with options that improve quality of life and long-term prognosis for patients.
- Global reach: Through our global operational network, we work to expand access to innovative treatments across regions.
Sobi’s focus within immunology
Immunology has been at the core of Sobi’s work for many years. Our portfolio addresses auto-inflammatory and autoimmune conditions, which are serious, disabling, and sometimes life-threatening disorders requiring targeted, evidence-based treatment strategies.
Our commitment is to provide healthcare professionals with innovative, evidence-based options that enhance patient outcomes and quality of life. Collaboration is central to our approach, as we work closely with clinicians, patient organizations, and other stakeholders to ensure timely access to effective treatments for those who need them most.
High unmet medical need
Half of all people affected by rare diseases are children. While each disease may impact only a small number of people, collectively they represent a significant clinical and public health challenge.
Despite advances in medicine, rare diseases remain an area of substantial unmet medical need. Of the estimated 10,000 rare diseases worldwide, only about 5% currently have approved treatments. This underscores the importance of continued innovation and collaboration to expand therapeutic options.